Psychedelics are unique from other drugs in that the experiences they make available often demand an ethic of living. Ethics of a spiritual, therapeutic, or exploratory quality develop spontaneously because of the transcendental nature of the experience. Contemporary psychedelic drug taking went through a cycle which peaked in 1972 and declined about 1979. A slow resurgence of interest is indicated by receding irrational hysteria and the emergence of new information. Psychedelic drug takers often adopt ethics similar to those in societies where such drugs are already an accepted part of culture, ethics which constructively integrate the experience with ongoing life.
Get full access to this article
View all access options for this article.
References
1.
AndersonEdward F.1980Peyote; the Divine Cactus. Tucson, Arizona: University of Arizona Press.
2.
BeckerHoward S.1967History, Culture, and Subjective Experience: An Exploration of the Social Bases of Drug Induced Experiences. J. Health and Social Behavior8(3):163–176.
3.
BunceRichard1979Social and Political Sources of Drug Effects: The Case of Bad Trips on Psychedelics. J. of Drug Issues9:213–233.
4.
de RiosMarlene Dobkin1972Visionary Vine: Psychedelic Healing in the Peruvian Amazon. San Francisco: Chandler.
5.
FernandezJ. W.1972Tabernanthe iboga: Narcotic Ecstasies and the Work of the Ancestors. Flesh of the Gods: The Ritual Use of Hallucinogens, FurstPeter, ed. New York: Praeger.
6.
GracieZarkov1985Gracie and Zarkov on LSD and MDA. High Frontiers2:10.
7.
GrinspoonL.BakalarJames B.1979Psychedelic Drugs Reconsidered. New York: Basic Books.
8.
KuselHienz1965Ayahuasca Drinkers Among the Chama Indians. Psychedelic Review6:58–66.
